CN105997347A - Disposable compression hemostatic wound dressing - Google Patents
Disposable compression hemostatic wound dressing Download PDFInfo
- Publication number
- CN105997347A CN105997347A CN201610324859.7A CN201610324859A CN105997347A CN 105997347 A CN105997347 A CN 105997347A CN 201610324859 A CN201610324859 A CN 201610324859A CN 105997347 A CN105997347 A CN 105997347A
- Authority
- CN
- China
- Prior art keywords
- layer
- pressing plate
- flexible member
- moisture absorption
- plate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000006835 compression Effects 0.000 title claims abstract description 21
- 238000007906 compression Methods 0.000 title claims abstract description 21
- 230000002439 hemostatic effect Effects 0.000 title abstract 5
- 238000010521 absorption reaction Methods 0.000 claims abstract description 25
- 239000008280 blood Substances 0.000 claims abstract description 19
- 210000004369 blood Anatomy 0.000 claims abstract description 18
- 229920002635 polyurethane Polymers 0.000 claims abstract description 15
- 239000004814 polyurethane Substances 0.000 claims abstract description 15
- 239000000463 material Substances 0.000 claims abstract description 10
- 229920001661 Chitosan Polymers 0.000 claims abstract description 9
- 239000004745 nonwoven fabric Substances 0.000 claims abstract description 8
- 229920000728 polyester Polymers 0.000 claims abstract description 5
- 230000023597 hemostasis Effects 0.000 claims description 25
- 239000002671 adjuvant Substances 0.000 claims description 18
- 230000001681 protective effect Effects 0.000 claims description 8
- 239000004744 fabric Substances 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 4
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 10
- 230000000740 bleeding effect Effects 0.000 abstract description 9
- 206010052428 Wound Diseases 0.000 abstract description 6
- 208000027418 Wounds and injury Diseases 0.000 abstract description 6
- 230000036407 pain Effects 0.000 abstract description 3
- 230000029663 wound healing Effects 0.000 abstract description 3
- 206010061218 Inflammation Diseases 0.000 abstract description 2
- 230000004054 inflammatory process Effects 0.000 abstract description 2
- 239000002390 adhesive tape Substances 0.000 abstract 3
- 239000011086 glassine Substances 0.000 abstract 2
- 239000000123 paper Substances 0.000 abstract 2
- 241000894006 Bacteria Species 0.000 abstract 1
- 230000002301 combined effect Effects 0.000 abstract 1
- 230000003467 diminishing effect Effects 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 229920002994 synthetic fiber Polymers 0.000 abstract 1
- 208000032843 Hemorrhage Diseases 0.000 description 12
- 230000000025 haemostatic effect Effects 0.000 description 6
- 210000001367 artery Anatomy 0.000 description 5
- 210000002321 radial artery Anatomy 0.000 description 5
- 210000003462 vein Anatomy 0.000 description 5
- 229940030225 antihemorrhagics Drugs 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 230000004872 arterial blood pressure Effects 0.000 description 3
- 206010034754 petechiae Diseases 0.000 description 3
- -1 polypropylene Polymers 0.000 description 3
- 230000000472 traumatic effect Effects 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- 239000004820 Pressure-sensitive adhesive Substances 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 208000027744 congestion Diseases 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 206010011703 Cyanosis Diseases 0.000 description 1
- 206010011985 Decubitus ulcer Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 206010018852 Haematoma Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 208000004210 Pressure Ulcer Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000001194 anti-hemostatic effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 238000004868 gas analysis Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 230000037324 pain perception Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/132—Tourniquets
- A61B17/1322—Tourniquets comprising a flexible encircling member
- A61B17/1325—Tourniquets comprising a flexible encircling member with means for applying local pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive bandages or dressings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B2017/12004—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord for haemostasis, for prevention of bleeding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/23—Carbohydrates
- A61L2300/232—Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/42—Anti-thrombotic agents, anticoagulants, anti-platelet agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Materials Engineering (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Reproductive Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Materials For Medical Uses (AREA)
- Surgical Instruments (AREA)
Abstract
The invention provides disposable compression hemostatic wound dressing. The disposable compression hemostatic wound dressing is composed of upper-layer glassine release paper, a lower-layer polyurethane non-woven fabric adhesive tape and a protection pad layer between the upper-layer glassine release paper and the lower-layer polyurethane non-woven fabric adhesive tape, wherein the protection pad layer comprises a pressing plate, an auxiliary material block moisture absorption cushion, a blood absorption layer and an elastic component, the auxiliary material block moisture absorption cushion is formed in a manner that upper-layer and lower-layer anti-sticking PE films with tiny holes wrap a chitosan auxiliary material block, the elastic component is wrapped by upper-layer and lower-layer water-proof and liquid-proof polyester non-woven fabrics and is adhered to the pressing plate, the pressing plate is adhered to a lower-layer non-woven fabric adhesive tape, and the blood absorption layer is made of artificial fiber non-woven fabric and is positioned between the auxiliary material block moisture absorption cushion and the elastic component. According to the disposable compression hemostatic wound dressing, through the combined effect of the pressing plate and the elastic component, the hemostatic wound dressing applies a pressing force to the bleeding point continuously, and meanwhile, the chitosan auxiliary material block is utilized for carrying out bleeding-stopping covering protection on the bleeding part, so that the effects of relieving pain, diminishing inflammation, resisting bacteria and promoting the wound healing are achieved.
Description
Technical field
The invention belongs to medical apparatus field, be specifically related to a kind of single use hemostasis by compression dressing.
Background technology
Present stage, it is clinical modal that dynamic (quiet) arteries and veins punctures, and blood gas analysis mensuration, the invasive be more common in patient with severe symptoms's diagnosis and treatment activity are monitored or through dynamic (quiet) arteries and veins infusion medicine etc..Hemostasis by compression and covering protection after puncturing radial artery and dorsal artery of foot etc. clinically the most only use the tourniquet repeatedly sterilized; haemostatic effect tightens up skin simply by the effect of pressing; the most single; poor flexibility due to tourniquet; patient is made to feel tight; the most uncomfortable; and so blood vessel is had the biggest damage; the most do not possess pain relieving, antiinflammatory, the antibacterial and effect of promotion wound healing; thus it is susceptible to the clinical infection of wound surface; and inducing anaphylaxis, more severe patient causes the generation that dynamic (quiet) arteries and veins is scorching；Generally using swab stick to carry out pressing haemostatic it addition, hospital carries out hemostasis covering protection to systemic vein after donating blood, draw blood and transfusing blood, bleeder needs at least to press 5 minutes, the most time-consumingly bothers.
Summary of the invention
For above technical disadvantages, it is an object of the invention to design a kind of hemostasis by compression dressing, make oppressive force be concentrated mainly on hemostasis site targetedly, simple to operate, need not annular tourniquet, reduce the discomfort of patient, promote clinical efficacy.
The technical solution used in the present invention is: single use hemostasis by compression dressing, it is made up of upper strata Ge Laxin release paper, lower floor's polyurethane Non-woven tape and the protective pad layer between both, protective pad layer includes pressing plate, adjuvant block moisture absorption pad, blood absorption layer, flexible member, is from top to bottom followed successively by adjuvant block moisture absorption pad, blood absorption layer, flexible member, pressing plate；Adjuvant block moisture absorption pad is anti-paste by upper and lower two-layer and is wrapped in chitosan adjuvant block by the PE film of fine holes and forms, flexible member is wrapped up by the waterproof liquid proof polyester non-woven fabric of upper and lower two-layer and is sticked on pressing plate, pressing plate sticks on lower nonwoven cloth rubber belt, and blood absorption layer material is artificial fabric nonwoven cloth between adjuvant block moisture absorption pad and flexible member.Polyurethane Non-woven tape is due to attachment polyurethane and medical pressure-sensitive adhesive, therefore there is the most elastic and adhesion, the present invention is in use, the oppressive force in hemostasis site increases along with the elongation of polyurethane Non-woven tape, if one side is pasted after elongating 2cm respectively, the oppressive force (about 100mmHg) that can effectively stop blooding can be obtained, after pasting 1 hour, still can keep about the 80% of initial value, and patient will not experience the strongest tight sense and constriction.
Preferably, the shape of pressing plate is designed as middle narrow, two ends width；According to mechanics principle, being designed to middle narrow, two ends width, pressing plate two ends are curved under being easier in the case of stress, and suffered power is easier to be transmitted in the middle of pressing plate and the connecting portion of flexible member, thus increases the oppressive force to bleeding part.The material of pressing plate can be polypropylene, can there is different size, the different bleeding parts of hemostasis by compression as required, pressing plate can make different sizes, the pressing plate of different size is selected according to different bleeding parts, petechia is positioned at the narrow human body (the venous blood collection point as) having radian can use undersized pressing plate, otherwise uses large-sized pressing plate.
Preferably, thickness of compressive plate controls at 1 mm-1.5mm.
Preferably, described flexible member is spring, and spring is taper.
Preferably, described flexible member is by upper head plate, bottom plate and is embedded in S type elastic plate between the two and forms, and upper head plate is upper convex, and described S type elastic plate is three.
The invention have the benefit that the present invention passes through the compound action of pressing plate and flexible member; make this bleeding-stopping dressing lasting give one, petechia oppressive force; utilize chitosan adjuvant block that bleeding part carries out the covering protection that stops blooding simultaneously; play pain relieving, antiinflammatory, the antibacterial and effect of promotion wound healing; solve existing hospital haemostatic effect difference and easily cause the technical problem of traumatic infection, effectively preventing traumatic infection and the generation of dynamic (quiet) arteries and veins inflammation.
Accompanying drawing explanation
Fig. 1 is the structural representation of the present invention；
Fig. 2 is the structural representation of the protective pad layer of the present invention；
Fig. 3 is the another kind of structural representation of protective pad layer of the present invention；
Fig. 4 is the extended length graph of a relation of oppressive force intensity of the present invention and polyurethane Non-woven tape；
In figure: the release paper of 1-lattice Racine；2-polyurethane Non-woven tape；3-pressing plate；4-protective pad layer；5-chitosan adjuvant block；6-blood absorption layer；7-spring；8-S type elastic plate；9-upper head plate；10-bottom plate.
Detailed description of the invention
The detailed description of the invention of the present invention is discussed in detail below in conjunction with the accompanying drawings, as shown in Figure 1, 2, the first detailed description of the invention of the present invention is: a kind of single use hemostasis by compression dressing, it is made up of upper strata Ge Laxin release paper 1, lower floor's polyurethane Non-woven tape 2 and the protective pad layer 4 between both, it is fine and close, uniformly that lattice Racine release paper 1 has quality, there are good internal intensity and transmittance, are possible to prevent bleeding-stopping dressing folded deformation；Polyurethane Non-woven tape 2 is due to attachment polyurethane and medical pressure-sensitive adhesive, therefore there is the most elastic and adhesion, as shown in Figure 4, in use, the oppressive force in hemostasis site increases the present invention along with the elongation of polyurethane Non-woven tape, if one side is pasted after elongating 2cm respectively, the oppressive force (about 100mmHg) that can effectively stop blooding can be obtained, after pasting 1 hour, still can keep about the 80% of initial value, and patient will not experience the strongest tight sense and constriction.
Protective pad layer includes pressing plate 3, adjuvant block moisture absorption pad, blood absorption layer 6, flexible member, is from top to bottom followed successively by adjuvant block moisture absorption pad, blood absorption layer 6, flexible member, pressing plate 3；Adjuvant block moisture absorption pad 5 is anti-paste by upper and lower two-layer and is wrapped in chitosan adjuvant block 5 by the PE film of fine holes and forms, flexible member uses volute spring 7, volute spring 7 is by upper and lower two layers polyester non-woven wraps and sticks on pressing plate 3, polyester non-woven fabric has waterproof liquid proof effect, anti-Hemostatic Oral Liquid or tissue fluid are immersed in flexible member, pollute flexible member；Pressing plate 3 sticks on lower floor's polyurethane Non-woven tape 2, and blood absorption layer 6 is between adjuvant block moisture absorption pad and volute spring, and material is artificial fabric nonwoven cloth, has good absorbability；Chitosan adjuvant block with chitosan (extract of chitin) as principle active component, be equipped with glycerol, polyhexamethylene guanidine, vitamin E are adjuvant, the present invention has obvious inhibitory activity to the growth of multiple pathogen, to staphylococcus aureus, escherichia coli, Candida albicans killing rate up to 99%, and to skin and mucosa nonirritant, it is applicable to skin and the treatment of mucosa traumatic infection, and the healing of wound can be promoted.
Further, pressing plate 3 can be designed to middle narrow, and the shape that two ends are wide, THICKNESS CONTROL is at 1 mm
-1.5mm；So advantage of design is: pressing plate 3 two ends are curved under being easier in the case of stress, suffered power is easier to be transmitted in the middle of pressing plate and the connecting portion of spring, pressure suffered by whole pressing plate can all concentrate on spring, thus increases the oppressive force to bleeding part, helps hemostasis.The material of pressing plate is polypropylene, can there is different size, the different bleeding parts of hemostasis by compression as required, pressing plate can make different sizes, the pressing plate of different size is selected according to different bleeding parts, petechia is positioned at the narrow human body (the venous blood collection point as) having radian can use undersized pressing plate, otherwise uses large-sized pressing plate.
As shown in Figure 3, another embodiment of the invention is that described flexible member can be to use another kind of form, by upper head plate 9, bottom plate 10 be embedded in S type elastic plate 8 between the two and form, upper head plate is upper convex, the pressure that elastic plate is accumulated can be concentrated, S type elastic plate could be arranged to three, it is also possible to arranges different numbers according to the force value that different puncture site need；Other designs are identical with the first embodiment.
Clinical trial result:
The effect of clinical observation Accepted Coronary Artery Intervention Treatment via Radial Artery (PCI) site of puncture application different pressures Hemostasis afterwards, patient 50 example of trans-radial path row coronary intervention it is randomly divided into use radial artery pressure tourniquet group (n=25) and uses hemostasis by compression dressing group (n=25) of the present invention, observing the effect of two groups of patient hemostasis, complication rate and comfort.Result PCI postoperative use radial artery pressure tourniquet and use hemostasis by compression dressing group of the present invention all can successfully be stopped blooding, the effect of hemostasis has notable difference, the patient of use radial artery pressure tourniquet apparently higher than using hemostasis by compression dressing of the present invention, also has notable difference in terms of hemorrhage, hematoma, numbness, cyanosis in terms of pain perception and skin pressure ulcer.
Optimal pressing haemostatic method after clinical observation venous blood collection, 50 example venous blood collection patients are randomly divided into 2 groups, it is respectively experimental group and matched group, experimental group uses double joint cotton swab pressing haemostatic 5 minutes, matched group uses hemostasis by compression dressing of the present invention 5 minutes, observes the incidence rate of the hemorrhage and congestion of 2 groups, compare the effect of 2 groups of pressing haemostatics after 5 minutes, result show the hemorrhage of experimental group and congestion incidence rate apparently higher than matched group, comparing difference statistically significant (P ＜ 0.05).
The foregoing is only the preferred embodiments of the present invention, be not limited to the present invention, for the person of ordinary skill of the art, the present invention can have various modifications and variations；All within the spirit and principles in the present invention, any modification, equivalent substitution and improvement etc. made, should be included within the scope of the present invention.
Claims (5)
1. single use hemostasis by compression dressing, by upper strata Ge Laxin release paper, lower floor's polyurethane Non-woven tape and the composition of the protective pad layer between both, it is characterized in that: described protective pad layer includes pressing plate, adjuvant block moisture absorption pad, blood absorption layer, flexible member, described adjuvant block moisture absorption pad is anti-paste by upper and lower two-layer and is wrapped in chitosan adjuvant block by the PE film of fine holes and forms, described flexible member is wrapped up by the waterproof liquid proof polyester non-woven fabric of upper and lower two-layer and is sticked on pressing plate, described pressing plate sticks on lower floor's polyurethane Non-woven tape, described blood absorption layer material is artificial fabric nonwoven cloth between adjuvant block moisture absorption pad and flexible member.
Single use hemostasis by compression dressing the most according to claim 1, it is characterised in that: described platen shape is middle narrow, two ends width.
Single use hemostasis by compression dressing the most according to claim 2, it is characterised in that: described thickness of compressive plate is 1 mm-1.5mm.
4. according to the single use hemostasis by compression dressing described in claim 1 or 2 or 3, it is characterised in that: described flexible member is spring, and described spring is taper.
5. according to the single use hemostasis by compression dressing described in claim 1 or 2 or 3, it is characterized in that: described flexible member is by upper head plate, bottom plate and is embedded in S type elastic plate between the two and forms, described upper head plate is upper convex, and described S type elastic plate is three.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610324859.7A CN105997347A (en) | 2016-05-17 | 2016-05-17 | Disposable compression hemostatic wound dressing |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610324859.7A CN105997347A (en) | 2016-05-17 | 2016-05-17 | Disposable compression hemostatic wound dressing |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105997347A true CN105997347A (en) | 2016-10-12 |
Family
ID=57098044
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610324859.7A Withdrawn CN105997347A (en) | 2016-05-17 | 2016-05-17 | Disposable compression hemostatic wound dressing |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105997347A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106420167A (en) * | 2016-10-18 | 2017-02-22 | 广东美捷威通生物科技有限公司 | Vacuum liquid locking treatment system |
| CN109498272A (en) * | 2019-01-18 | 2019-03-22 | 李映辉 | A kind of infusion hemostatic adhesive bandage |
| CN114053034A (en) * | 2021-11-19 | 2022-02-18 | 青岛大学 | Expansion pressurization band-aid/application and preparation method |
-
2016
- 2016-05-17 CN CN201610324859.7A patent/CN105997347A/en not_active Withdrawn
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106420167A (en) * | 2016-10-18 | 2017-02-22 | 广东美捷威通生物科技有限公司 | Vacuum liquid locking treatment system |
| CN106420167B (en) * | 2016-10-18 | 2022-05-24 | 广东美捷威通生物科技有限公司 | Vacuum lock liquid treatment system |
| CN109498272A (en) * | 2019-01-18 | 2019-03-22 | 李映辉 | A kind of infusion hemostatic adhesive bandage |
| CN109498272B (en) * | 2019-01-18 | 2024-02-02 | 李映辉 | Transfusion hemostatic patch |
| CN114053034A (en) * | 2021-11-19 | 2022-02-18 | 青岛大学 | Expansion pressurization band-aid/application and preparation method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9795516B2 (en) | Wound dressing garment | |
| KR102491335B1 (en) | Adhesive Film Bandage for medical compression | |
| EP2797451B1 (en) | Post surgical breast dressing | |
| CN206896454U (en) | One kind treats varix of lower limb Special sock | |
| CN105997347A (en) | Disposable compression hemostatic wound dressing | |
| CN205832007U (en) | Single use hemostasis by compression dressing | |
| CN106510948A (en) | Postoperative care dressing for anus disease | |
| CN207253425U (en) | Hemostatic adhesive bandage | |
| CN210228242U (en) | Local double-pressure tourniquet for general surgery department | |
| CN202740071U (en) | Bleeding-stop device | |
| CN210277485U (en) | Medical application with pressure | |
| CN210144863U (en) | Novel anti-slip dressing for children burn and scald | |
| CN217286734U (en) | Airtight needle-stick injury prevention peripheral vein indwelling needle of slow-pressing skin-friendly butterfly wing and slow-pressing skin-friendly structure thereof | |
| CN219185031U (en) | Adhesive bandage tearing type plaster cold compress for navel and eye parts | |
| CN214342940U (en) | Foot pressure sore prevention device | |
| US20060241541A1 (en) | Therapeutic bandage for the heel of the foot | |
| US20210085007A1 (en) | Multilayer Garments Worn During Wound Care | |
| CN214679183U (en) | Toe portion prevents pressing sore protective sheath | |
| CN211609943U (en) | Radial artery hemostasis compressor | |
| CN210472392U (en) | Adhesive bandage | |
| CN207940969U (en) | The medical dressing of sepage after a kind of anti-abdominocentesis | |
| WO2023244852A2 (en) | Elevation apparatus, system and methods of use | |
| CN111789654A (en) | Wartime adhesive air bag type arteriovenous quick hemostatic device | |
| Nather et al. | New Generation Dressings for Diabetic Wounds | |
| TWM330079U (en) | Hemostatic device |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20161012 |